Index S&P 500
P/E -
EPS (ttm) -7.52
Insider Own 11.70%
Shs Outstand 389.00M
Perf Week -2.90%
Market Cap 10.44B
Forward P/E -
EPS next Y -7.46
Insider Trans -0.00%
Shs Float 344.88M
Perf Month 13.74%
Enterprise Value 6.05B
PEG -
EPS next Q -2.08
Inst Own 73.43%
Short Float 18.66%
Perf Quarter -15.33%
Income -2.90B
P/S 3.39
EPS this Y -3.16%
Inst Trans 2.62%
Short Ratio 6.41
Perf Half Y 2.06%
Sales 3.08B
P/B 1.11
EPS next Y 22.12%
ROA -20.97%
Short Interest 64.34M
Perf YTD -35.69%
Book/sh 24.16
P/C 2.04
EPS next 5Y 19.26%
ROE -27.50%
52W High 59.73 -55.24%
Perf Year -54.57%
Cash/sh 13.14
P/FCF -
EPS past 3/5Y - -42.94%
ROIC -28.75%
52W Low 23.15 15.51%
Perf 3Y -78.63%
Dividend Est. -
EV/EBITDA -
Sales past 3/5Y -43.99% 121.86%
Gross Margin 45.74%
Volatility 5.28% 5.17%
Perf 5Y -62.36%
Dividend TTM -
EV/Sales 1.97
EPS Y/Y TTM 51.07%
Oper. Margin -106.34%
ATR (14) 1.36
Perf 10Y -
Dividend Ex-Date -
Quick Ratio 3.77
Sales Y/Y TTM -38.95%
Profit Margin -94.31%
RSI (14) 51.59
Recom 2.89
Dividend Gr. 3/5Y - -
Current Ratio 3.93
EPS Q/Q 36.16%
SMA20 1.41%
Beta 1.99
Target Price 43.42
Payout -
Debt/Eq 0.08
Sales Q/Q -41.08%
SMA50 2.95%
Rel Volume 0.84
Prev Close 26.83
Employees 5800
LT Debt/Eq 0.07
Earnings Aug 01 BMO
SMA200 -10.83%
Avg Volume 10.04M
Price 26.74
IPO Dec 07, 2018
Option/Short Yes / Yes
EPS/Sales Surpr. 28.75% 28.16%
Trades
Volume 8,471,864
Change -0.34%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-13-25 Initiated
Citigroup
Neutral
$40
Feb-18-25 Downgrade
Barclays
Overweight → Equal Weight
$111 → $45
Jan-29-25 Downgrade
Goldman
Buy → Neutral
$99 → $51
Dec-18-24 Downgrade
Argus
Buy → Hold
Dec-10-24 Resumed
BofA Securities
Underperform
$41
Nov-19-24 Initiated
Berenberg
Hold
$42
Nov-18-24 Upgrade
HSBC Securities
Hold → Buy
$58
Nov-15-24 Initiated
Wolfe Research
Underperform
$40
Oct-17-24 Initiated
Bernstein
Mkt Perform
$55
Sep-13-24 Downgrade
Oppenheimer
Outperform → Perform
Sep-13-24 Downgrade
JP Morgan
Neutral → Underweight
$88 → $70
Sep-13-24 Downgrade
Jefferies
Buy → Hold
$120 → $65
Aug-28-24 Upgrade
HSBC Securities
Reduce → Hold
$82
Aug-07-24 Upgrade
Deutsche Bank
Sell → Hold
$85 → $80
Aug-05-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$125 → $90
Feb-26-24 Downgrade
HSBC Securities
Hold → Reduce
$75 → $86
Jan-02-24 Upgrade
Oppenheimer
Perform → Outperform
$142
Nov-29-23 Initiated
Canaccord Genuity
Hold
$82
Nov-03-23 Upgrade
HSBC Securities
Reduce → Hold
$89 → $69
Nov-02-23 Downgrade
Deutsche Bank
Hold → Sell
$125 → $60
Show Previous Ratings
Oct-13-25 12:21PM
Oct-10-25 08:50AM
05:07AM
Oct-08-25 05:50PM
Oct-07-25 06:14AM
(Pharmaceutical Technology)
08:50AM
Loading…
Oct-06-25 08:50AM
Oct-03-25 11:48AM
Oct-02-25 05:50PM
10:32AM
09:30AM
01:35AM
Oct-01-25 04:20PM
02:48PM
02:08PM
Sep-30-25 07:30AM
05:50PM
Loading…
Sep-25-25 05:50PM
06:55AM
(Pharmaceutical Technology)
05:34AM
Sep-24-25 07:31PM
07:01PM
05:26PM
Sep-23-25 09:01PM
10:16AM
(The Wall Street Journal)
07:00AM
Sep-22-25 04:46PM
10:21AM
09:53AM
Sep-21-25 09:25AM
Sep-19-25 04:28PM
(Investor's Business Daily)
+5.23%
03:10PM
05:50PM
Loading…
Sep-18-25 05:50PM
01:53PM
(Investor's Business Daily)
05:00AM
Sep-17-25 04:31PM
10:04AM
09:28AM
07:24AM
Sep-16-25 11:40AM
11:15AM
06:00AM
Sep-15-25 08:56AM
04:00AM
Sep-14-25 05:30AM
Sep-13-25 01:56PM
Sep-12-25 07:55PM
07:43PM
05:45PM
05:16PM
05:15PM
04:21PM
(The Wall Street Journal)
04:01PM
02:56PM
02:25PM
02:11PM
(The Wall Street Journal)
01:37PM
01:28PM
12:33PM
12:11PM
11:35AM
03:00AM
Sep-11-25 10:05AM
08:06AM
Sep-10-25 04:00AM
Sep-09-25 08:00PM
(The Wall Street Journal)
Sep-08-25 02:26PM
01:41PM
Sep-07-25 02:28PM
04:42AM
Sep-05-25 11:33AM
10:27AM
(Investor's Business Daily)
Sep-04-25 12:44AM
Sep-03-25 03:08PM
Sep-02-25 07:00AM
04:57AM
01:34AM
12:33AM
Aug-31-25 08:40AM
Aug-29-25 11:51AM
Aug-28-25 12:04PM
07:55AM
(Pharmaceutical Technology)
04:56AM
03:49AM
Aug-27-25 11:32PM
04:27PM
(Investor's Business Daily)
03:05PM
01:56PM
01:42PM
(The Wall Street Journal)
01:24PM
Aug-26-25 08:31PM
Aug-25-25 10:30AM
(Associated Press Finance) -6.53%
08:10AM
(Pharmaceutical Technology)
Aug-24-25 02:17AM
Aug-22-25 06:02PM
09:25AM
Aug-21-25 07:00AM
Aug-20-25 04:23PM
Aug-19-25 09:06AM
Aug-18-25 03:58AM
Aug-17-25 09:30AM
Aug-14-25 09:00AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hussain Abbas Director Jun 11 '25 Sale 28.00 312 8,736 580 Jun 12 04:22 PM Hussain Abbas Director Jun 11 '25 Proposed Sale 28.00 312 8,736 Jun 11 10:06 AM Bancel Stephane Chief Executive Officer Mar 03 '25 Buy 31.22 160,314 5,004,318 9,210,686 Mar 04 04:27 PM SAGAN PAUL Director Mar 03 '25 Buy 31.76 31,620 1,004,251 312,027 Mar 04 04:24 PM Klinger Shannon Thyme Chief Legal Officer Dec 09 '24 Sale 44.68 529 23,637 20,446 Dec 10 04:08 PM Klinger Shannon Thyme Officer Dec 09 '24 Proposed Sale 44.68 529 23,637 Dec 09 03:18 PM Klinger Shannon Thyme Chief Legal Officer Dec 03 '24 Sale 43.30 112 4,849 19,837 Dec 04 05:11 PM Hoge Stephen President Dec 03 '24 Sale 43.30 314 13,595 1,443,904 Dec 04 05:08 PM Klinger Shannon Thyme Officer Dec 03 '24 Proposed Sale 43.30 112 4,849 Dec 03 04:11 PM Hoge Stephen Officer Dec 03 '24 Proposed Sale 43.30 314 13,595 Dec 03 03:23 PM Mock James M Chief Financial Officer Nov 29 '24 Sale 42.79 1,420 60,761 11,066 Dec 02 04:26 PM Klinger Shannon Thyme Chief Legal Officer Nov 29 '24 Sale 42.79 1,418 60,675 19,717 Dec 02 04:19 PM Hoge Stephen President Nov 29 '24 Sale 42.79 291 12,452 1,443,567 Dec 02 04:15 PM Hoge Stephen Officer Nov 29 '24 Proposed Sale 42.79 291 12,452 Nov 29 03:54 PM Klinger Shannon Thyme Officer Nov 29 '24 Proposed Sale 42.79 1,418 60,675 Nov 29 03:49 PM Mock James M Officer Nov 29 '24 Proposed Sale 42.79 1,420 60,761 Nov 29 03:35 PM Hoge Stephen President Nov 11 '24 Sale 46.10 277 12,771 1,443,248 Nov 12 04:14 PM Hoge Stephen Officer Nov 11 '24 Proposed Sale 46.10 277 12,771 Nov 12 09:27 AM